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SeizuresGarcinielliptone FC (GFC) isolated from hexanic fraction seed extract of species Platonia insignisMart. It is widely
used in folk medicine to treat skin diseases in both humans and animals as well as the seed decoction has been
used to treat diarrheas and inﬂammatory diseases. However, there is no research on GFC effects in the central
nervous system of rodents. The present study aimed to evaluate the GFC effects at doses of 25, 50 or 75 mg/kg
on seizure parameters to determine their anticonvulsant activity and its effects on amino acid (γ-aminobutyric
acid (GABA), glutamine, aspartate and glutathione) levels as well as on acetylcholinesterase (AChE) activity in
mice hippocampus after seizures. GFC produced an increased latency to ﬁrst seizure, at doses 25 mg/kg (20.12 ±
2.20 min), 50 mg/kg (20.95± 2.21min) or 75 mg/kg (23.43± 1.99min)when comparedwith seizedmice. In ad-
dition, GABA content of mice hippocampus treated with GFC75 plus P400 showed an increase of 46.90% when
compared with seized mice. In aspartate, glutamine and glutamate levels detected a decrease of 5.21%, 13.55%
and 21.80%, respectively in mice hippocampus treated with GFC75 plus P400 when compared with seized
mice. Hippocampus mice treated with GFC75 plus P400 showed an increase in AChE activity (63.30%) when
compared with seized mice. The results indicate that GFC can exert anticonvulsant activity and reduce the fre-
quency of installation of pilocarpine-induced status epilepticus, as demonstrated by increase in latency to ﬁrst sei-
zure and decrease in mortality rate of animals. In conclusion, our data suggest that GFC may inﬂuence in
epileptogenesis and promote anticonvulsant actions in pilocarpine model by modulating the GABA and gluta-
mate contents and of AChE activity in seized mice hippocampus. This compound may be useful to produce neu-
ronal protection and it can be considered as an anticonvulsant agent.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Epilepsy is a disorder in brain function characterized by recurrent
and unpredictable seizures. The prevalence in general population is ap-
proximately 1% (Stahl, 2010), affecting at least 50 million peopleworld-
wide (Goldenberg, 2010). The central nervous system (CNS) has high
amino acid concentrations that bind to the postsynaptic receptors, re-
ceptors γ-amino butyric acid (GABA), which is involved in excitatory
action and inhibitory action, and glutamate, which is involved in excit-
atory action, are considered the most important neuroactive amino
acids (Golan et al., 2009; Goodman and Gilman, 2012). In currenty, Federal University of Piaui,
ga, 64048-901 Teresina, Piauí,
itas).context, it is important to evaluate the effects of natural products on
participation of these and other amino acids in neurotransmission sys-
tems in epilepsy models.
In recent years, evidence showed that natural products used as folk
remedies have contributed signiﬁcantly for the discovery of modern
medicines worldwide (Costa Junior et al., 2011). In particular, studies
with species Platonia insignis Mart have demonstrated special interest
in evaluating regional ﬂora and its safety and efﬁcacy in preclinical trials
(Santos et al., 2013). In addition, many herbal medicines can be active
on CNS, and have at least a hypothetical potential for chronic conditions
such as epilepsy that does not respond well to conventional treatments
(Quintans et al., 2007; Campelo et al., 2010; Marques et al., 2011).
This work proposes to study a compound isolated from species
P. insignis, popularly known in Brazil as “bacuri”. Belonging to the family
Clusiaceae, P. insignis is popularly used as antidepressants (Bilia et al.,
2002; Viana et al., 2005), being equivalent to ﬂuoxetine and imipramine,
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sponds to a polyprenylated acylphloroglucinol benzophenonewhich has
a core (diphenylmethanone) substituted groups isoprenylates (3-meth-
yl-2-butenila) and 2-isopropenyl-hex-5-enyl. It shows a pattern of triple
one oxygenation of aromatic rings of core diphenylmethanone accompa-
nied by additional intramolecular cyclization, which yields a bicyclic
system of nine carbon atoms. The compound is termed garcinielliptone
FC [C38H50O6; (8,8-dimethyl-1-(3,4-dihidroxibenzoil)-2-hydroxy-3,5-
di(γ,γ-dimethylallyl)-7-(2-isopropenilhex-5-enyl)-7α-H-trans-bicyclo
[3.3.1]nona-2-en-4,9-dione)] (Fig. 1).
In the study of pilocarpine-induced seizures in rodents, several
plants have shown promising results. Therefore, there is a growing
need to research for possible pharmacological properties of plants in
search of new therapies showing efﬁcacy, no serious adverse effects
and low cost. Within this perspective, several research groups have
been studying the anticonvulsant potential of natural compounds in
pilocarpine-induce seizures. Over the years, the pilocarpine model has
been widely used since the 80s as it replicates the phenomenological
features of human temporal lobe epilepsy (Turski et al., 1983, 1989).
Therefore, the present study aimed to evaluate the GFC effects on
seized parameters to investigate anticonvulsant activity and its effects
on amino acids (γ-aminobutyric acid (GABA), glutamine, aspartate
and glutathione) levels and of acetylcholinesterase enzyme (AChE)
activity inmice hippocampus after pilocarpine-induced seizures, to pro-
vide literature data, particularly in area of epilepsy.2. Materials and methods
2.1. Extraction and isolation
The seeds were dried at 55 °C and powdered. After crush 848.2 was
extractedwith hexane (63%,w/w). The hexane extractwas subjected to
silica gel and eluted with n-hexane containing increased amounts of
ethanol extract (EtOAc) and washed with methanol at process end.
The resultant hexane extract yields 51 subfractions. The fraction 33
was further puriﬁed on thin layer chromatography (TLC) plates and
eluted with chloroform–methanol (CHCl3–MeOH) (9:1) to yield GFC
(22 mg) thus being identiﬁed by spectroscopic methods (Costa Junior
et al., 2011).Fig. 1. Garcinielliptone FC (1/1a) isolated from seeds of P. insignis (8,8-dimethyl-1-(3,4-dihyd
trans-bicyclo [3.3.1]nona-3-en-2,9-dione (1a)).2.2. Animals
Mice (Mus musculus) of Swiss strain, males and females, weighing
between 25 and 35 g, from Central Animal Facility of Agricultural
Sciences Center, Federal University of Piaui, were used in experiments.
The animals received water and diet ad libitum and were maintained
under controlled lighting (cycle 12 h light/dark) and temperature
(25 ± 2 °C). The project was approved by Ethics Committee in Animal
Experimentation of Federal University of Piaui (072/2012).
2.3. Drug treatment
The GFC was emulsiﬁed with 0.05% Tween 80 (Sigma, USA) and dis-
solved in 0.9% saline vehicle. The animals were pretreated with pilocar-
pine at dose 400 mg/kg intraperitoneally (i.p.) emulsiﬁed in vehicle,
with GFC at doses 25, 50 and 75 mg/kg orally (o.r.) during the evalua-
tion of anticonvulsant activity and 30min later, GFC pretreated animals
received pilocarpine at dose 400 mg/kg. The dose of 75 mg/kg was se-
lected for analysis of action mechanism, therefore, showed a greater in-
crease in seizure latency when compared to other doses (p b 0.05).
Various toxicity studies were performed to ensure the use of this
compound. With regard to acute toxicity, the 50% lethal dose (LD50)
was determined orally in mice and rats, which resulted in deaths at
doses greater than 5.0 g/kg, ensuring the use of doses 25, 50 and
75 mg/kg (data not shown).
2.4. Experimental protocol
Mice were divided into ﬁve groups (n = 10, per groups). The ﬁrst
groupwas used as control and received the vehicle (0.05% Tween 80 dis-
solved in 0.9% saline; vehicle group) and the second group was treated
with pilocarpine hydrochloride (400 mg/kg, i.p.; P400 groups). The re-
maining groups were treated with GFC at doses of 25, 50 and 75 mg/kg
(GFC25, GFC50 and GFC75, groups, respectively). Thirty minutes after
GFC administration, mice were treated with pilocarpine (i.p.) at dose of
400 mg/kg (GFC25 plus P400, GFC50 plus P400 and GFC75 plus P400
groups, respectively). Behavioral changes were observed during 1 h.
The observed parameters were a number of peripheral cholinergic,
tremors, stereotyped movements (SM), seizures, status epileptic (SE),
and mortality rate. The SE was deﬁned as continuous seizures during aroxybenzoyl)-4-hydroxy-3,5-di(δ,δ-dimethylallyl)-7-(2-isopropenylhex-5-enyl)-7α-H-
Table 1
Behavioral alterations in mice treated with garcinielliptone FC (GFC) in pilocarpine-induced seizures.
Groups Cholinergic reactions (%) Tremors (%) Stereotyped movements (%) Status epilepticus (%) Survival rate (%)
P400 100 100 100 100 00
DZP 5 plus P400 100 100 100 50⁎ 50⁎
GFC25 plus P400 100 100 13.75⁎ 32.5⁎ 32.5⁎
GFC50 plus P400 100 100 18.75⁎ 63.75⁎,⁎⁎ 65⁎,⁎⁎
GFC75 plus P400 100 100 15.75⁎ 85⁎,⁎⁎,⁎⁎⁎ 90.1⁎,⁎⁎,⁎⁎⁎
Mice (25–30 g, 2 months-old) were treatedwith a single dose of pilocarpine (400 mg/kg, i.p., n = 10). Animals were acutely pretreated, with garcinielliptone FC (GFC) at doses of 25, 50
or 75 mg/kg (o.r.) and 30 min after receiving pilocarpine 400 mg/kg (P400, i.p.; n = 10). Diazepam 5 mg/kg (DZP, positive control, o.r.) and 30 min after receiving P400 (i.p.; n = 10).
Results for cholinergic reaction, tremors, stereotyped movements, status epilepticus and survival rat were expressed as percentage of number of animals in each experimental group.
⁎ p b 0.05, when compared with P400 group;
⁎⁎ p b 0.05, when compared with GFC25 plus P400 group;
⁎⁎⁎ p b 0.05 when compared with GFC50 plus P400 group.
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(1983). Mortality rate was determined 1 h after pilocarpine-induced SE.
In another step of experiment, 30 min after treatment with vehicle,
GFC75mg/kg andGFC75 plus P400,mice (n= 10, per groups)were ob-
served for at least 1 h to detect installation latency of ﬁrst seizure, num-
ber of animals that had status epileptic and number of animals that died
after administration of pilocarpine (P400).
After 24 h of observation, animals were euthanized and their brains
removed for dissection of hippocampus to measure the neurochemical
changes in amino acid levels and AChE activity to evaluate the GFC effect
on these neurotransmitter systems. γ-Aminobutyric acid (GABA), gluta-
mine, glutathione and aspartate levels as well as acetylcholinesterase
(AChE) enzymatic activity inmice hippocampuswere studied in 10% ho-
mogenates prepared in sodium phosphate buffer (150 mmol/L, pH 7.4).
The protein concentration was measured according to the method de-
scribed by Lowry et al. (1951) as well as acetylcholinesterase (AChE) ac-
tivity was measured by themethod of Ellman et al. (1961). Results were0
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Fig. 2. Latency to ﬁrst seizure (2A), latency to installation of status epilepticus (2B), and latency
seizures. The animals were pre-treated with pilocarpine 400 mg/kg, (n= 10, i.p., P400 group),
400 mg/kg (P400, i.p.; n= 10), or diazepam 5 mg/kg (DZP 5, positive control, o.r.) and 30min
i.p., n = 10, control group). The group GFC25, 50 or 75 mg/kg plus P400 group were pre-treate
Thedifferences in experimental groupsweredeterminedby analysis of variance (ANOVA) follow
bp b 0.05 when compared with DZP 5 plus P400 group, cp b 0.05 when compared with GFC25expressed as μmol per g tissue for amino acid levels and theAChE activity
was expressed in μmol acetylcholine hydrolyzed/mg protein/min.
2.5. Behavioral study
Previously, another study showed that status epileptic and deaths oc-
curred between 1 and 24 h, respectively, after injection of pilocarpine
(Turski et al., 1983). All experimental groups of GFC were observed
after treatment, according to experimental protocols, during 24 h
observation.
The following parameters observed were a number of peripheral
cholinergic signs, tremors, stereotyped (miosis, piloerection, chromo-
dacryorrhea, diarrhea and masticatory automatisms), continuous
snifﬁng, paw licking, rearing and wet dog shakes that persisted for
10–15 min, clonic movements of forelimb, head bobbing and tremors.
These behavioral changes progressed to motor limbic status epilepticus
as previously described by Turski et al. (1983). Limbic seizures persisted0
10
20
30
a
a
a
a
L
a
te
n
c
y 
to
 i
n
s
ta
ll
a
ti
o
n
o
f 
s
ta
tu
s
(m
in
u
te
s
)
a,b
a,b,c
a
B
of death (2C) in mice pretreated with garcinielliptone FC (GFC) after pilocarpine-induced
or GFC at doses 25, 50 and 75 mg/kg, (n = 10, o.r.) and 30 min after received pilocarpine
after receiving P400 (i.p.; n= 10) and or vehicle (0.05% Tween 80 dissolved in 0.9% saline,
d with GFC at doses 25, 50 and 75 mg/kg for 30min before with pilocarpine (400 mg/kg).
ed by t-Student–Newman–Keuls post hoc test. ap b 0.05whencomparedwith P400group,
plus P400 group. GFC = garcinielliptone FC; P400 = pilocarpine.
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Fig. 3.Garcinielliptone FC (GFC) effects on amino acids level inmice hippocampus after pilocarpine-induced seizures. The animalswere pretreatedwith pilocarpine 400 mg/kg, (n=8, i.p.,
P400 group), or GFC at dose 75 mg/kg, (n=8, o.r.) and 30min after receivedpilocarpine 400 mg/kg (P400, i.p.; n=8), or diazepam5 mg/kg (DZP 5, positive control, o.r.) and 30min after
received P400 (i.p.; n = 8) and or vehicle (0.05% Tween 80 dissolved in 0.9% saline, i.p., n = 8, control group). The group GFC75 plus group were pre-treated with GFC75 mg/kg, 30 min
before with P400. The differences in experimental groups were determined by analysis of variance (ANOVA) followed by t-Student–Newman–Keuls post hoc test. ap b 0.05 when com-
pared with vehicle group; bp b 0.05, when compared with P400 group. GFC = Garcinielliptone FC; P400 = Pilocarpine.
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animals died.
2.6. Statistical analysis
Results are expressed asmeans±SD for the number of experiments.
The t-Student–Newman–Keuls test was used for multiple comparisons
of means of two groups of data whose differences were considered sta-
tistically signiﬁcant at p b 0.05. Differences in experimental groups
were determined by analysis of variance (ANOVA).
3. Results
3.1. Behavioral study of mice pretreated with garcinielliptone
FC and pilocarpine
All animals treated with pilocarpine (400 mg/kg, i.p., n = 10; P400
groups), which presented after 3–10 min the peripheral cholinergic
signs (PCS) (miosis, piloerection, chromodacryorrhea, diarrhea and
masticatory automatisms), stereotyped movements (SM) (increased
activity of biting, scratching, chewing, rearing and/or wet-dog shakes)0
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Fig. 4. GFC effects on acetylcholinesterase enzyme (AChE) activity in mice hippocampus after
(n = 8, i.p., P400 group), or GFC at dose 75 mg/kg, (n = 8, o.r.) and 30 min after received p
o.r.) and 30 min after received P400 (i.p.; n = 8) and or vehicle (0.05% Tween 80 dissolved
with GFC75 mg/kg, 30 min before with P400. The differences in experimental groups were d
hoc test. ap b 0.05 when compared with vehicle group; bp b 0.05, when compared with P400 gand tremors that progressed to seizures and status epilepticus (SE).
The mortality rate was 100% in this group (Table 1).
Pilocarpine induced the ﬁrst seizure after 2.2 ± 0.24 min. According
to Fig. 2, GFC caused an increase in latency to theﬁrst epileptic seizure in-
duced by P400, at doses 25 mg/kg (1.63 ± 0.17 s), 50 mg/kg (2.92 ±
0.23 s) and 75 mg/kg (3.40 ± 0.13 s), of 25.90%, 43.37% and 87.95%
when comparedwith P400 group, (p b 0.05), respectively. GFC produced
an increased latency for development of pilocarpine-induced status
epilepticus at doses 25 mg/kg (20.12 ± 2.20 min), 50 mg/kg (20.95 ±
2,21 min) and 75 mg/kg (23.43 ± 1.99 min), of 37.34%, 43.00% and
59.93% when compared with P400 group (p b 0.05), respectively. Fur-
thermore, theGFC produced an increased latency to death induced by pi-
locarpine at doses 25 mg/kg (15.60 ± 1.28 min), 50 mg/kg (18.04 ±
1.60 min) and 75 mg/kg (20.67 ± 1.10 min) of 37.68%, 59.22% and
82.43% when compared with P400 group (p b 0.05), respectively
(Fig. 2). Similarly, DZP 5 plus P400 showed an increase latency for
development of pilocarpine-induced status epilepticus as well as in
latency to death induced by pilocarpine when compared with vehicle.
On the other hand, GFC75 plus 75 detected an increase in latency
to death induced by pilocarpine when compared with DZP 5 plus P400
(p b 0.05).Vehicle
GFC 75
P400
DZP 5 plus P400
a,b
GFC 75 plus P400
pilocarpine-induced seizures. The animals were pretreated with pilocarpine 400 mg/kg,
ilocarpine 400 mg/kg (P400, i.p.; n = 8), or diazepam 5 mg/kg (DZP 5, positive control,
in 0.9% saline, i.p., n = 8, control group). The group GFC75 plus group were pre-treated
etermined by analysis of variance (ANOVA) followed by t-Student–Newman–Keuls post
roup. GFC = Garcinielliptone FC; P400 = Pilocarpine.
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zures, which is related to regulation of inhibitory neurotransmission in
seizures and status epilepticus, was altered in GFC plus P400 groups
when compared with P400 group (p b 0.05) as there was an increase
in GABA concentration 52.01% in mice pretreated with GFC at dose of
75 mg/kg (GFC75 plus P400 group) when compared with P400 group
(p b 0.05) (Fig. 3).
In amino acid levels (glutamate and glutamine), during the acute
phase of seizures, there were decreases of 13.55% and 21.80% in
glutamine and glutamate levels in mice hippocampus pretreated with
GFC at dose 75 mg/kg and after 30 min from receiving pilocarpine
400 mg/kg (GFC75 plus P400) when compared with P400 group, re-
spectively (p b 0.05) (Fig. 3). On the other hand, there were no changes
in aspartate level in mice hippocampus of all groups when compared
with vehicle (p N 0.05). In addition, none of amino acid studies veriﬁed
changes in GFC75 and DZP 5 plus P400 (p N 0.05).
Mice pretreated with GFC75 and received pilocarpine 400 mg/kg
(GFC75 plus P400) 30min after showed an increase of 65.3% in AChE ac-
tivity when compared with P400 group (p b 0.05, Fig. 4). On the other
hand, there were no changes in enzymatic activity in DZP 5 plus P400
and GFC75 groups when compared with vehicle (p N 0.05). In addition,
the group treated with pilocarpine 400 mg/kg (P400) showed a de-
crease in AChE activity when compared with vehicle (p b 0.05, Fig. 4).4. Discussion
In animal epilepsy models, several plants have shown anticonvul-
sant effects. Among these studies in plants that can be highlighted,
Hypericum perforatum L. (Rego et al., 2007), Hypericum grandifolium
Choisy (Sánchez-Mateo et al., 2009), Hypericum caprifoliatum Cham. &
Schltdl (Viana et al., 2005), Abrus precatorius L., Clausena anisataWilld
and Hoslundia opposita Vahl (Moshi et al., 2005), Citrus limon
(Campelo et al., 2011) demonstrated satisfactory results in epilepsy
model by pilocarpine-induced seizures. It is important to mention that
many medicinal plants have activities on CNS and they have at least a
hypothetical potential to affect chronic conditions such as anxiety, de-
pression, headaches or epilepsy that does not respond well to conven-
tional treatments (Rego et al., 2007; Pedersen et al., 2009). Studies
have shown that the use of plants help to expand the therapeutic arse-
nal in this area and reduces costs with available treatments (Sarmento
et al., 2014; Marques et al., 2014), reinforcing the need for completion
of this study and justifying the importance of the evaluation of new
compounds isolated from natural products.
Our results suggest that GFC can exert anticonvulsant activity
against and reduce the number of animal presented pilocarpine-in-
duced status epilepticus, as demonstrated by an increase in the latency
of onset of seizures and decrease in mortality rate of animals. Previous
data showed that increase in free radicals content during seizures
leads to an increase in glutamate concentration and consequently
there is the facilitation to the spread of seizures and neuronal damages
in various brain regions (Barros et al., 2007; Kersante et al., 2013). Re-
cently, our research group demonstrated that GFC has antioxidant effect
against nitric oxide (NO) and hydroxyl radicals generated in vitro and
that the ethanolic extract of seeds of P. insignis, species from which
GFCwas isolated, was able to promote an increased latency for develop-
ment of picrotoxin- and pentylenetetrazol-induced seizures (Costa
Junior et al., 2011).
The data found regarding behavioral changes in rodents after
pilocarpine-induced seizures, are in accordancewith observations previ-
ously described in other studies (Marinho et al., 1998; Santos et al., 2008;
Freitas, 2009; Santos et al., 2011). In the present study, it was demon-
strated that oral administration at GFC at doses 25, 50 and 75 mg/kg re-
duced the number of animals that showed seizures and status epilepticus
pilocarpine-induced, and also reduced the mortality rate. The results
suggest that GFC may have an important anticonvulsant action inpilocarpine-induced seizures, probably by potentiation or increase of
hippocampal inhibitory neurotransmission.
Once associated with pilocarpine-induced seizures, it has been
reported previously that the an increase in GABA concentration after
status epilepticus and a decrease after 24 h of acute phase of seizures
(Freitas et al., 2011) can occur in this epilepsy model. Benzodiazepines
such as diazepam and clonazepam do not interfere with any of behav-
ioral parameters observed in mice, suggesting that the GABAergic sys-
tem does not interact with peripheral effects mediated by pilocarpine.
In turn, the GFC demonstrated efﬁcacy in reducing the number of ani-
mals that presented seizures and evolved to status epilepticus, and also
decreased the mortality rate in mice treated with GFC. Reinforcing the
hypothesis about the possible action mechanism of GFC can be directly
related with GABAergic system.
Excitatory amino acids such as glutamate and aspartate are involved
in generation and expression of epileptic seizures in mammalian brain
(Kersante et al., 2013). After its interaction with the NMDA-subtype of
glutamate receptor, glutamate induces the Ca2+ inﬂux, increasing the
neuronal nitric oxide synthase (nNOS) activity and nitric oxide (NO)
production which may contribute to neuronal damage (Tome et al.,
2010). As noted previously GFC was able to reduce NO levels in
in vitro experimental models, which may contribute to the anticonvul-
sant effect observed in vivo in the present study. On the other hand, in-
hibitory amino acids such as GABA and glycine counteract the neuronal
excitation. GABA, acting through the GABAA receptor, increases the
chloride inﬂux, leading to hyperpolarization of cell membrane and an-
tagonism of epileptic seizures. Thus, our results suggest that the anti-
convulsant effects of the GFC may be mediated by modulation of the
levels correlated with mediators of excitatory and inhibitory neuro-
transmitter systems.
The involvement of cholinergic mechanisms of pilocarpine is well-
established in epilepsy (Turski et al., 1989). Acetylcholinesterase
(AChE) activity has a pivotal role in cholinergic neurotransmission and
hydrolysis of neurotransmitter acetylcholine to terminate the transmis-
sion of nerve impulses. The lack of results in AChE activity probably
owing abnormally high of acetylcholine levels at cholinergic synapses
can induce seizures. The accumulation of acetylcholine results in exces-
sive stimulation ofmuscarinic andnicotinic receptors. Signs of poisoning
are seen as increased salivation, difﬁculty breathing, tremors, seizures
and death. Increased cholinergic activity in brain is probably related to
the initial phase of status epilepticus (McDonough and Shih, 1997;
Fernandes, 2013). The cholinergic activity produced byGFC is supposed-
ly supported by reduction in seizures andmortality rates. In addition, in
correspondence with this hypothesis, the GFC increases the latency to
the ﬁrst seizure and installation latency to status epilepticuswhich may
enhance its probable mechanism of action anticonvulsant.
5. Conclusion
This study is extremely relevant since the data presented in this re-
port with respect to effects on the central nervous system in the
pilocarpine-induced seizures in mice model is being presented for the
ﬁrst time in the literature regarding the subject of this study.
The results show that GFC decreases the frequency of pilocarpine-
induced seizures and increases survival rate. According to a literature
review, these GFC effects in mortality rate observed during the acute
phase of pilocarpine-induced seizures were not previously registered.
Thus, these ﬁndings may have important implications for understand-
ing the pathophysiological epilepsy mechanisms in order to promote
new advances in the development of antiepileptic drugs. The GFC also
protected mice against status epilepticus observed during pilocarpine-
induced seizures. Due to its prominent neuropharmacological effects
observed in our experiments during the acute phase of seizures, new
neurochemical studies with GFC are underway to elucidate the action
mechanism and justify the use of this natural compound as a potential
therapeutic agent.
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